Posted by Michael Wonder on 31 Dec 2021
Schedule of Pharmaceutical Benefits - 1 January 2022 update
1 January 2022 - The January 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The January issue of the Schedule includes a few new/revised listings:
- Dapagliflozin propanediol monohydrate (Forxiga) - new indication
- Encorafenib (Braftovi) - new indication
- Palbociclib (Ibrance) - new formulation
